1.

晚期NSCLC患者ERCC1 C8092A、118多态性与含铂化疗疗效的关系

Genotype frequencies in patients with advanced NSCLC and response to cisplatin-based chemotherapy according to genotype

Genotype	No. of patients (n/%)			χ2	P
	Frequencies	CR+PR	SD+PD
CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.
C8092A				0.14	0.71
CC	36 (40.0)	12 (33.3)	24 (66.7)
CA+AA	54 (60.0)	16 (29.6)	38 (70.4)
118				0.64	0.43
CC	53 (58.9)	17 (32.1)	36 (67.9)
CT+TT	37 (41.1)	9 (24.3)	28 (75.7)